Inventor · disambiguated record
James R. Falsey
Also filed as: FALSEY JAMES R · FALSEY JAMES RICHARD
18 granted patents·5 pending applications·123 citations·filing 2003–2025
92Inventor score
Top patents by PatentIndex Score
23 records- 0194US7897619B2Heterocyclic modulators of PKBAMGEN INC·Filed 2008·Granted Mar 1, 2011·42 cites·41 claims
- 0293US7700593B2Imidazo- and triazolo-pyridine compounds and methods of use thereofAMGEN INC·Filed 2007·Granted Apr 20, 2010·35 cites·13 claims
- 0390US10905772B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2018·Granted Feb 2, 2021·6 cites·18 claims
- 0482US7759337B2Phthalazine compounds and methods of useAMGEN INC·Filed 2006·Granted Jul 20, 2010·7 cites·14 claims
- 0582US7745449B2Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of useAMGEN INC·Filed 2007·Granted Jun 29, 2010·6 cites·6 claims
- 0680US2025121056A1Method of treating or ameliorating metabolic disorders using glp-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (gipr)AMGEN INC·Filed 2024·Application pending·0 cites
- 0779US8497269B2Phthalazine compounds as p38 map kinase modulators and methods of use thereofTASKER ANDREW·Filed 2009·Granted Jul 30, 2013·4 cites·12 claims
- 0879US8318718B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Nov 27, 2012·4 cites·94 claims
- 0977US8637500B2Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitorsALLEN JENNIFER R·Filed 2009·Granted Jan 28, 2014·3 cites·18 claims
- 1077US7144888B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Dec 5, 2006·9 cites·25 claims
- 1174US8247409B2Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of useHONG FANG-TSAO·Filed 2009·Granted Aug 21, 2012·4 cites·12 claims
- 1272US7148221B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Dec 12, 2006·1 cites·19 claims
- 1369US12214051B2Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR)AMGEN INC·Filed 2021·Granted Feb 4, 2025·0 cites·14 claims
- 1469US7511044B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Mar 31, 2009·1 cites·5 claims
- 1563US8716281B2Pyrimidine compounds that inhibit anaplastic lymphoma kinaseBRYAN MARIAN C·Filed 2011·Granted May 6, 2014·1 cites·41 claims
- 1654US7332511B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 19, 2008·0 cites·19 claims
- 1751US2011118234A1Urea Compounds as Gamma Secretase ModulatorsBISWAS KAUSTAV·Filed 2009·Application pending·0 cites
- 1849US8759532B2Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitorsAMGEN INC·Filed 2012·Granted Jun 24, 2014·0 cites·80 claims
- 1949US2025276080A1Glucagon receptor agonists and conjugates to glucose-dependent insulinotropic polypeptide antagonistsAMGEN INC·Filed 2025·Application pending·0 cites
- 2046US9636418B2Potent and selective inhibitors of NAV1.7AMGEN INC·Filed 2014·Granted May 2, 2017·0 cites·24 claims
- 2144US2006069110A1Substituted heterocyclic compounds and methods of useANDERSEN DENISE L·Filed 2005·Application pending·0 cites
- 2243US10344060B2Potent and selective inhibitors of Nav1.7AMGEN INC·Filed 2014·Granted Jul 9, 2019·0 cites·25 claims
- 2342US2007054916A1Aryl nitrogen-containing bicyclic compounds and methods of useAMGEN INC·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James R. Falsey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →